ÂÜÀòÂÒÂ×

Georgeta Puscalau has a diverse and extensive work experience in the pharmaceutical and biotechnology industry. They have held various senior leadership positions, including Senior Vice President Quality at Tune Therapeutics since 2023, Senior Vice President & Chief Quality Officer at Resilience from 2021 to 2022, and Vice President Quality at BMS/Celgene/Juno Therapeutics from 2017 to 2020.

Prior to these roles, Georgeta worked as Vice President Quality at Spectrum Pharmaceuticals from 2014 to 2017, Director, Quality Assurance & Quality Control at Shire Pharmaceuticals/Organogenesis from 2013 to 2014, and Director Quality Control at Genzyme from 2012 to 2013. They also served as Senior Director/Director, Corporate Quality Control at Dendreon Corporation from 2005 to 2011.

Georgeta began their career at Inex Pharmaceuticals in 1998, starting as a QC Associate/R&D Associate and later becoming a Senior Manager/Manager, Quality Management/Project Manager. They worked at Inex Pharmaceuticals until 2005.

Prior to their pharmaceutical industry experience, Georgeta worked as a Chemical Engineer at Melana S.A. from 1989 to 1996.

Throughout their career, Georgeta has gained extensive expertise in quality control, quality assurance, and project management, making them a highly experienced and skilled professional in the field.

Georgeta Puscalau obtained a B.S (M.S) degree in Chemical Engineering from Gheorghe Asachi Technical University of Iasi. Georgeta enrolled in this program from 1984 to 1989.